Howard Sklamberg

Final Rule On Cannabis Rescheduling Could Publish In Fall 2024, Sklamberg Says

The Rescheduling Of Cannabis: What It Means, Next Steps, And Implications For Industry

Sklamberg Discusses Cannabis Rescheduling On NPR's 1A Podcast

FDA Publishes Final Guidance On Reporting Listed Drug Amounts

FDA Issues Final Rule To More Closely Align FDA Medical Device Quality System Requirements With International Consensus Standard ISO 13485

Scientific Evidence For Cannabis Rescheduling Difficult To Challenge, Says Sklamberg

FDA Authorizes Florida's Plan Under FD&C Act Section 804 To Import Prescription Drugs From Canada

FDA Announces Draft Guidance To Continue Implementing Remote Interactive Evaluations Of Drug Manufacturing Establishments And Biomedical Research

Reschedule Or Deschedule? Sklamberg Predicts Rescheduling Of Cannabis In Mindset Value Podcast

HHS Takes An Important Step To Form A Biopharmaceutical Manufacturing Preparedness Consortium To Expand Domestic Biopharmaceutical Manufacturing Capability